Genotypic analysis of cutaneous T-cell lymphomas

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Cutaneous T-cell lymphoma (CTCL) diagnosis can be challenging, especially in early or advanced stages.
• Identifying neoplastic T-cells is crucial for accurate diagnosis and treatment.
• The T-cell receptor (TCR) beta-chain gene is a key marker for T-cell clonality.

Purpose of the Study:

• To investigate the utility of TCR beta-chain gene rearrangement analysis in diagnosing CTCL.
• To differentiate between neoplastic and reactive T-cell proliferations in skin, blood, and lymph nodes.
• To assess the diagnostic value of this method in various stages of CTCL.

Main Methods:

• DNA was extracted from skin, blood, and lymph node specimens of 23 patients with known or suspected CTCL.
• T-cell receptor (TCR) beta-chain gene rearrangement was analyzed using Southern blotting or PCR.
• Histopathological examination of lymph nodes was performed concurrently.

Main Results:

• Clonal rearrangement of the TCR beta-chain gene was detected in all samples from patients with advanced CTCL, including Sézary syndrome and mycosis fungoides (tumor stage).
• This rearrangement was present even in lymph nodes showing only dermatopathic lymphadenitis.
• In contrast, patients with plaque-stage mycosis fungoides or suspected early CTCL showed a germline configuration of the TCR beta-chain gene.

Conclusions:

• DNA analysis of TCR beta-chain gene rearrangement is a valuable tool for diagnosing extracutaneous involvement in advanced CTCL.
• This molecular method aids in distinguishing neoplastic T-cell clones from polyclonal or oligoclonal proliferations.
• The findings support the use of TCR gene rearrangement analysis for improving CTCL diagnosis and management.